MicroRNA-143 Is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer

Technology in Cancer Research and Treatment - United States
doi 10.1177/1533033819827309
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

A microRNA Signature Associated With Pathological Complete Response to Novel Neoadjuvant Therapy Regimen in Triple-Negative Breast Cancer

Tumor Biology
MedicineCancer Research
2017English

MicroRNA-221/222 Negatively Regulates Estrogen Receptor Α and Is Associated With Tamoxifen Resistance in Breast Cancer.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

MicroRNA-143 Regulates Adipogenesis by Modulating the MAP2K5–ERK5 Signaling

Scientific Reports
Multidisciplinary
2014English

MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

MicroRNA-143 Down-Regulates Hexokinase 2 in Colon Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Conversion of Immunohistochemical Markers and Breast Density Are Associated With Pathological Response and Prognosis in Very Young Breast Cancer Patients Who Fail to Achieve a Pathological Complete Response After Neoadjuvant Chemotherapy

Cancer Management and Research
Oncology
2019English

Relevance of Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2016English

MicroRNA-710 Regulates Multiple Pathways of Carcinogenesis in Murine Metastatic Breast Cancer

PLoS ONE
Multidisciplinary
2019English

Complete Pathological Response in Patients With Locally Advanced Cancer of Breast and Positive Her2/Neu With Neoadjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy